scispace - formally typeset
Search or ask a question

Cancer statistics of world 


Best insight from top research papers

Cancer is a significant cause of morbidity and mortality worldwide, with an increasing number of cases and deaths over the past decade . In 2020, there were an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths globally . The most commonly diagnosed cancers were female breast, lung, colorectal, prostate, and stomach cancers . Lung cancer remained the leading cause of cancer death, followed by colorectal, liver, stomach, and female breast cancers . The global cancer burden is expected to rise to 28.4 million cases in 2040, with a larger increase in transitioning countries due to demographic changes and increasing risk factors associated with globalization and a growing economy . Efforts to build a sustainable infrastructure for cancer prevention and care in transitioning countries are critical for global cancer control .

Answers from top 5 papers

More filters
Papers (5)Insight
The paper provides global cancer statistics for 2018, estimating 181 million new cancer cases and 96 million cancer deaths worldwide. Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death. Breast cancer is the most commonly diagnosed cancer among females.
The paper compares cancer statistics between the Global Health Estimates (GHE) and Global Health Data Exchange (GHDx) registries. It finds that cancer-related DALYs are similar in both registries, but cancer mortality is slightly overestimated in GHDx. The paper does not provide specific worldwide cancer statistics.
The paper provides statistics on cancer worldwide, stating that it affects over 19 million people per year and causes 10 million deaths. It is the second most common cause of death globally.
The paper provides cancer statistics for the year 2020 worldwide. It estimates 19.3 million new cases of cancer and 10.0 million deaths from cancer in 2020. The most commonly diagnosed cancers were female breast, lung, and prostate cancers, while the most common causes of cancer death were lung, liver, and stomach cancers.
The paper provides global cancer statistics for 2020, estimating 19.3 million new cancer cases and 10.0 million cancer deaths worldwide. It also highlights the most commonly diagnosed and leading causes of cancer.

Related Questions

What are the current statistics on advanced cancer prevalence worldwide?4 answersThe current statistics on advanced cancer prevalence worldwide indicate that there were an estimated 28.8 million people living with cancer in 2008, with breast cancer being the most prevalent globally. Stomach cancer is predominant in Eastern Asia, while prostate cancer is dominant in North America, Oceania, and parts of Europe. Lung and colorectal cancers are among the top cancers contributing to mortality globally, with stomach and liver cancers showing high mortality rates in Asia. The incidence of colorectal cancer has been decreasing in Japan but increasing in China. Breast cancer rates are notably higher in the United States and Europe compared to Asian countries, with increasing rates across all regions. These statistics highlight the need for long-term care strategies to manage prevalent cancer types worldwide.
What are the latest global cancer statistics in terms of incidence and mortality rates?5 answersThe latest global cancer statistics reveal that in 2020, there were an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths worldwide. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, with 2.3 million new cases, while lung cancer remained the leading cause of cancer death with 1.8 million deaths. Transitioned countries had 2 to 3 times higher incidence rates compared to transitioning countries, while mortality rates varied slightly. However, transitioning countries had significantly higher death rates for female breast and cervical cancers. The global cancer burden is projected to rise to 28.4 million cases in 2040, with transitioning countries experiencing a larger increase due to demographic changes and associated risk factors.
Global cancer statistics 2023?4 answersIn 2023, it is projected that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States. Globally, in 2020, there were an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Breast cancer is the most commonly diagnosed cancer in females, while lung cancer is the leading cause of cancer death overall. The global cancer burden is expected to rise to 28.4 million cases in 2040, with a larger increase in transitioning countries. Cancer research funding has increased over the years, with investments reaching $8.51 billion in 2018. Cancer prevention measures, early detection, and treatment are crucial in reducing the global burden of cancer. Stomach and liver cancers are prevalent in Asia, while bladder cancer is common in the United States and Europe. Colorectal and breast cancers have high incidence rates worldwide.
What are general cancer statistics to underscore the global impact?4 answersCancer is a major cause of death globally, with increasing incidence and mortality rates. It is the leading cause of death in most regions, and the burden of cancer is rapidly growing worldwide. Breast, lung, prostate, and colorectal cancers account for a significant proportion of new cancer diagnoses globally. Occupational carcinogens contribute to a substantial disease burden, causing a significant number of cancer deaths and disability-adjusted life years (DALYs). Adolescents and young adults (AYAs) also experience a significant burden of cancer, with high incidence and mortality rates. Kidney, bladder, prostate, and testicular cancers have seen an increase in incidence rates over the years. These statistics underscore the global impact of cancer and highlight the need for prevention, control, and resource allocation to address this growing burden.
What is the world prevalence of cancer?5 answersThe worldwide prevalence of cancer is estimated to be 28.8 million cases in 2008, with breast cancer being the most prevalent globally. Cervix cancer is the most prevalent in Sub-Saharan Africa and Southern Asia, while prostate cancer dominates in North America, Oceania, and Northern and Western Europe. Stomach cancer is the most prevalent in Eastern Asia, oral cancer ranks highest in Indian men, and Kaposi sarcoma has the highest prevalence among men in 11 countries in Sub-Saharan Africa. In 2012, the global incidence of cancer was estimated to be 14 million new cases, with lung cancer being the most common. The number of cancer cases rose by 33% from 2005 to 2015, attributed to population aging, population growth, and changes in age-specific rates. Cancer affects more than 19 million people per year and is responsible for 10 million deaths globally, making it the second leading cause of death after cardiovascular disease.
Cancer statistics, 2023 answersIn 2019, it is projected that there will be 1,762,450 new cancer cases and 606,880 cancer deaths in the United States. The overall cancer death rate has been continuously declining, dropping by 27% from 1991 to 2016, resulting in approximately 2,629,200 fewer cancer deaths than expected if death rates had remained at their peak. However, there are still disparities in cancer mortality, with socioeconomic inequalities widening and racial gaps slowly narrowing. Access to high-quality healthcare plays a role in these disparities, particularly for young and middle-aged adults. Efforts to accelerate progress against cancer should focus on equitable dissemination of effective cancer prevention, early detection, and treatment strategies, as well as increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population.

See what other people are reading

Major human cancers are preventable: physiological stimuli induce a dopamine-thyroid-immune efficient mechanism?
5 answers
Physiological stimuli can indeed induce a mechanism involving dopamine, thyroid function, and immune efficiency that may prevent major human cancers. Studies suggest that upregulated hypothalamic dopaminergic activity, along with thyroid interactions, can potentially reduce the risk of cancers like breast, colon, lung, prostate, and melanoma. Dopamine has been shown to inhibit the synthesis of certain antibodies, potentially stimulating thyroid activity and impacting the immune system. Furthermore, the differentiation of neuroblastoma cells in response to stimuli leads to increased antigenicity, enhancing their susceptibility to immune cell-mediated lysis, indicating a link between neuronal differentiation, immune response, and cancer cell elimination. These findings highlight the intricate interplay between dopamine, thyroid function, and immune responses in potentially preventing major cancers.
Why does cystic fibrosis cause chronic inflammation?
4 answers
Cystic fibrosis (CF) induces chronic inflammation due to various factors. The dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) protein leads to mucus accumulation in the airways, fostering a vicious cycle of infection and inflammation. CF patients exhibit systemic inflammation even in the absence of detectable infections, suggesting dysregulated immune responses due to absent CFTR function. Moreover, CFTR dysfunction in immune cells and chronic infections create a proinflammatory environment that impairs bone mass maintenance in CF patients. The defective ion transport caused by CFTR absence results in airway surface liquid dehydration, trapping pathogens and triggering a highly inflammatory environment, ultimately leading to lung damage. Additionally, CF lungs show signs of accelerated aging pathology, termed "inflammaging," which exacerbates chronic inflammation and hinders the efficacy of CFTR modulator therapies.
Cancer AND incidence AND worldwide
5 answers
Global cancer burden data reveals that cancer remains a significant health challenge worldwide. In 2020, there were an estimated 19.3 million new cancer cases, with high-income countries (HIC) having the highest incidence rates for various cancers. The most commonly diagnosed cancers globally include female breast, lung, colorectal, prostate, and stomach cancers. Notably, lung cancer is the leading cause of cancer death, with a substantial impact on mortality rates. The incidence of common cancers in males in 2018 included lung, prostate, colorectal, stomach, and liver cancers, with lung cancer being the most prevalent. These findings underscore the ongoing need for effective cancer control measures to address the global burden of cancer and its varying trends across different income settings.
Is there a paper associated induce sarcopenia in the skeletal tissue?
4 answers
Sarcopenia, the age-related loss of muscle mass and function, can be induced by various factors. For instance, insulin resistance and adipokines may contribute to muscle derangements leading to muscle loss in chronic kidney disease (CKD) patients, potentially exacerbating renal function decline. Additionally, diseases like cancer, COPD, heart failure, and renal failure can lead to secondary sarcopenia, characterized by muscle wasting without the emphasis on muscle function. Furthermore, the evaluation of muscle mass and function is crucial for diagnosing sarcopenia, with measurements of muscle mass and strength being essential components. Therefore, while there isn't a specific paper solely focused on inducing sarcopenia in skeletal tissue, various conditions and diseases can contribute to the development of sarcopenia by affecting muscle mass and function.
Cancer AND incidence AND mortality
5 answers
The burden of cancer, as indicated by both its incidence and mortality rates, is a significant global health concern. Studies show that cancer trends are influenced by socioeconomic factors, with a strong correlation between Human Development Index (HDI) levels and cancer rates. Predictive models are being developed to estimate cancer incidence, especially for less common lethal cancers like brain cancer. The Global Burden of Diseases Study highlights the substantial and growing global burden of cancer, with variations across Sociodemographic Index (SDI) quintiles. Additionally, analyses of "Belt and Road" countries reveal high incidence and mortality rates for common cancers like lung, breast, and colorectal cancers, emphasizing the need for improved prevention and control policies. In the US, cancer remains a leading cause of death, with trends showing declines in mortality rates and variations based on sex and race.
Cancer AND incidence AND mortality AND worldwide
5 answers
Cancer's global burden is substantial, with an estimated 19.3 million new cases and almost 10 million deaths in 2020, excluding nonmelanoma skin cancer. Incidence rates have been rising, with a 44% increase in new cases and a 26% increase in cancer deaths over the past decade. While incidence and mortality rates for most cancers are decreasing in high-income countries, they are increasing in less developed and transitioning countries due to the adoption of unhealthy western lifestyles. The global cancer burden is projected to rise to 28.4 million cases in 2040, with a larger increase in transitioning countries, emphasizing the need for effective prevention measures and cancer care infrastructure in these regions. Efforts to address risk factors associated with globalization are crucial for controlling the escalating cancer rates worldwide.
Down syndrome in psychiatric nursing
4 answers
Down syndrome presents unique challenges in psychiatric nursing due to the increased prevalence of psychiatric comorbidities in individuals with this condition. Research indicates that individuals with Down syndrome have higher rates of psychosis and depression with psychotic features compared to those with other intellectual disabilities. Furthermore, psychiatric profiles differ between genetic syndromes, with individuals with Williams syndrome showing higher rates of anxiety disorders and psychosis than those with Down syndrome. Psychiatric nurses caring for individuals with Down syndrome must be prepared to address these specific mental health needs, provide emotional support, and navigate complex treatment decisions due to the intellectual disability associated with the syndrome. Understanding the psychiatric aspects of Down syndrome is crucial for delivering effective and tailored care to this vulnerable population.
Brisbane grammar school is bad?
5 answers
Brisbane Grammar School is not the focus of the provided contexts. However, the research sheds light on various aspects of education and school culture in Brisbane, particularly in Queensland. The studies discuss issues such as student engagement, social interactions, the importance of material culture in sporting activities, and the challenges of chronic diseases in public health. While there are mentions of schools in Brisbane, such as Brisbane Girls Grammar School, the specific quality or reputation of Brisbane Grammar School is not directly addressed in the given contexts. Therefore, based on the available information, it is not appropriate to make a definitive statement about Brisbane Grammar School's overall quality or performance.
How does the social cognitive theory affect the practitioner patient dynamic?
5 answers
The Social Cognitive Theory (SCT) plays a significant role in shaping the practitioner-patient dynamic by emphasizing factors such as behavior, personal beliefs, cognitive aspects, and the environment. SCT is utilized in various healthcare settings to enhance patient education and self-care practices, particularly in chronic conditions like diabetes mellitus and depression. It highlights the importance of self-efficacy, expectations, and self-control in influencing patient behavior and treatment compliance. Additionally, SCT underscores the role of mastery experiences in promoting positive changes in beliefs and behaviors, ultimately impacting the patient's perceived efficacy and agency in managing their health. By integrating SCT into clinical practice, practitioners can better understand and support patients in adopting healthier behaviors and improving treatment adherence, thereby positively influencing the practitioner-patient relationship.
How young adults with sickle cell disease define “being a good patient” in the adult healthcare system?
5 answers
Young adults with sickle cell disease define "being a good patient" in the adult healthcare system as a multifaceted concept influenced by various factors. Transitioning from pediatric to adult care is crucial, with patients and healthcare providers highlighting challenges during this period. Preparation for this transition promotes self-efficacy and enhances patients' ability to manage their healthcare effectively. Physicians treating sickle cell disease patients emphasize the importance of patient education on transition and identify patients' disease knowledge and healthcare system navigation as key barriers. Successful transition protocols, incorporating patient education, skill acquisition, and early preparation, are essential to improve medical care adherence and define what it means to be a good patient in the adult healthcare system for young adults with sickle cell disease.
What is the molecular mechanism behind the use of cancerized cells to determine alkaloides quantity?
5 answers
The molecular mechanisms behind the use of alkaloids in cancer cells involve various pathways to inhibit cancer progression and induce cell death. Alkaloids derived from natural products like plants exhibit anticancer properties by affecting signaling molecules involved in cell proliferation, differentiation, angiogenesis, metastasis, and apoptosis. These compounds can alter enzymes, transcription factors, and regulatory proteins like telomerase, STAT-3, and PI3K/Akt, impacting cancer cell survival and growth. Additionally, alkaloids such as ergot alkaloids have shown cytotoxic effects on tumor cells, with mechanisms independent of classical drug resistance factors, suggesting a potential to overcome drug resistance in cancer treatment. The anticancer activity of alkaloids like indicine N-oxide, noscapine, vinblastine, and vincristine involves inhibiting proliferation, inducing apoptosis, and overcoming multidrug resistance in various cancer types.